Macrophage Kdm6b controls the profibrotic transcriptome signature of foam cells

被引:26
|
作者
Neele, Annette E. [1 ]
Prange, Koen H. M. [1 ]
Hoeksema, Marten A. [1 ]
van der Velden, Saskia [1 ]
Lucas, Tina [2 ]
Dimmeler, Stefanie [2 ]
Lutgens, Esther [1 ,3 ]
Van den Bossche, Jan [1 ]
de Winther, Menno P. J. [1 ,3 ]
机构
[1] Acad Med Ctr, Dept Med Biochem, Expt Vasc Biol, Amsterdam, Netherlands
[2] Goethe Univ, Inst Cardiovasc Regenerat, Ctr Mol Med, Frankfurt, Germany
[3] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany
关键词
epigenetics; fibrosis; histone demethylase; histone H3K27me3; histone modification; Jmjd3; JmjdC; Kdm6b; macrophage; matrix biology; EPIGENETIC REGULATION; DEMETHYLASE JMJD3; GENE-EXPRESSION; POLARIZATION; DIFFERENTIATION;
D O I
10.2217/epi-2016-0152
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Aim: In order to identify regulators of foam cells, we studied the H3K27 demethylase Kdm6b (also known as Jmjd3), a known regulator of macrophages, in controlling the transcriptional profile of foam cells. Materials & methods: Foam cells from Kdm6b-deleted or Kdm6b wild-type mice were isolated and used for RNA-sequencing analysis. Results: Pathway analysis revealed that pro-fibrotic pathways were strongly suppressed in Kdm6b-deleted foam cells. Analysis of published datasets showed that foam cell formation induces these pro-fibrotic characteristics. Overlay of both datasets indicated that fibrotic genes which are induced upon foam cell formation, are reduced in the absence of Kdm6b. These data suggest that foam cell formation induces a pro-fibrotic gene signature in a Kdm6b-dependent manner. Conclusion: We identified Kdm6b as a novel regulator of the pro-fibrotic signature of peritoneal foam cells.
引用
收藏
页码:383 / 391
页数:9
相关论文
共 50 条
  • [31] SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade
    Romero, Octavio A.
    Vilarrubi, Andrea
    Alburquerque-Bejar, Juan J.
    Gomez, Antonio
    Andrades, Alvaro
    Trastulli, Deborah
    Pros, Eva
    Setien, Fernando
    Verdura, Sara
    Farre, Lourdes
    Martin-Tejera, Juan F.
    Llabata, Paula
    Oaknin, Ana
    Saigi, Maria
    Piulats, Josep M.
    Matias-Guiu, Xavier
    Medina, Pedro P.
    Vidal, August
    Villanueva, Alberto
    Sanchez-Cespedes, Montse
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [32] Refractory testicular germ cell tumors are highly sensitive to the targeting of polycomb pathway demethylases KDM6A and KDM6B
    Shokry, Doha
    Khan, Mehwish W.
    Powell, Christine
    Johnson, Samantha
    Rennels, Brayden C.
    Boyd, Raya I.
    Sun, Zhengyang
    Fazal, Zeeshan
    Freemantle, Sarah J.
    Parker, Maryanna H.
    Vieson, Miranda D.
    Samuelson, Jonathan P.
    Spinella, Michael J.
    Singh, Ratnakar
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [33] Pharmacological targeting of KDM6A and KDM6B, as a novel therapeutic strategy for treating craniosynostosis in Saethre-Chotzen syndrome
    Clara Pribadi
    Esther Camp
    Dimitrios Cakouros
    Peter Anderson
    Carlotta Glackin
    Stan Gronthos
    Stem Cell Research & Therapy, 11
  • [34] SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade
    Octavio A. Romero
    Andrea Vilarrubi
    Juan J. Alburquerque-Bejar
    Antonio Gomez
    Alvaro Andrades
    Deborah Trastulli
    Eva Pros
    Fernando Setien
    Sara Verdura
    Lourdes Farré
    Juan F. Martín-Tejera
    Paula Llabata
    Ana Oaknin
    Maria Saigi
    Josep M. Piulats
    Xavier Matias-Guiu
    Pedro P. Medina
    August Vidal
    Alberto Villanueva
    Montse Sanchez-Cespedes
    Nature Communications, 12
  • [35] KDM6B Regulates Estrogen-Mediated Osteogenic Differentiation of Human DMSCs
    Liu, Zhenqing
    Lee, Chang-Ryul
    Cui, Zhongkai
    Zhou, Michael
    Lee, Hye-Lim
    Lee, Min
    Wang, Cun-Yu
    Hong, Christine
    Aghaloo, Tara
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 190 - 190
  • [36] KDM6B Variants May Contribute to the Pathophysiology of Human Cerebral Folate Deficiency
    Han, Xiao
    Cao, Xuanye
    Cabrera, Robert M.
    Ramirez, Paula Andrea Pimienta
    Zhang, Cuilian
    Ramaekers, Vincent T.
    Finnell, Richard H.
    Lei, Yunping
    BIOLOGY-BASEL, 2023, 12 (01):
  • [37] Activation of epigenetic regulator KDM6B by Salmonella Typhimurium enables chronic infections
    Rana, Sarika
    Maurya, Sonalika
    Mohapatra, Gayatree
    Singh, Savita
    Babar, Rohan
    Chandrasekhar, Hridya
    Chamoli, Garima
    Rathore, Deepak
    Kshetrapal, Pallavi
    Srikanth, C., V
    GUT MICROBES, 2021, 13 (01)
  • [38] Genetic variants in the KDM6B gene are associated with neurodevelopmental delays and dysmorphic features
    Stolerman, Elliot S.
    Francisco, Elizabeth
    Stallworth, Jennifer L.
    Jones, Julie R.
    Monaghan, Kristin G.
    Keller-Ramey, Jennifer
    Person, Richard
    Wentzensen, Ingrid M.
    McWalter, Kirsty
    Keren, Boris
    Heron, Benedicte
    Nava, Caroline
    Heron, Delphine
    Kim, Katherine
    Burton, Barbara
    Al-Musafri, Fatima
    O'Grady, Lauren
    Sahai, Inderneel
    Escobar, Luis F.
    Meuwissen, Marije
    Reyniers, Edwin
    Kooy, Frank
    Lacassie, Yves
    Gunay-Aygun, Meral
    Schatz, Krista Sondergaard
    Hochstenbach, Ron
    Zwijnenburg, Petra J. G.
    Waisfisz, Quinten
    van Slegtenhorst, Marjon
    Mancini, Grazia M. S.
    Louie, Raymond J.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2019, 179 (07) : 1276 - 1286
  • [39] Pharmacological targeting of KDM6A and KDM6B, as a novel therapeutic strategy for treating craniosynostosis in Saethre-Chotzen syndrome
    Pribadi, Clara
    Camp, Esther
    Cakouros, Dimitrios
    Anderson, Peter
    Glackin, Carlotta
    Gronthos, Stan
    STEM CELL RESEARCH & THERAPY, 2020, 11 (01)
  • [40] Regulation of the JMJD3 (KDM6B) histone demethylase in glioblastoma stem cells by STAT3
    Sherry-Lynes, Maureen M.
    Sengupta, Sejuti
    Kulkarni, Shreya
    Cochran, Brent H.
    PLOS ONE, 2017, 12 (04):